Scott Brotze is a Gastroenterology physician. OpenAlex indexes 7 publications with 201 citations (h-index 2).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
13808 Professional Center Dr
Huntersville, NC 280787948
Telephone
704-377-4009Provider last certified this registry record 17 Jun 2025.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PENTAX of America, Inc.Program year20252 payments
- ABBVIE INC.Program year20251 payment
- Lilly USA, LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
87.6%Proton pump inhibitor39%Omeprazole61%Pantoprazole Sodium23%Dexlansoprazole Dr12%Esomeprazole Magnesium5%Part D<11 patientsGuanylate Cyclase-C Agonist11.7%Linzess100%Part D≥23 patients+ 10 more classes in this area
Cardiovascular
5.8%Bile Acid Sequestrant5.8%Colestipol Hcl100%Part D≥15 patientsBlood & clotting
2.4%Solutions for parenteral nutrition2.4%Peg 3350-Electrolyte100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The frequency of Barrett's esophagus in high-risk patients with chronic GERD
Gastrointestinal Endoscopy
2005 - SIGNIFICANT IMPAIRMENT OF GASTRIC MUCIN PRODUCTION DURING ADMINISTRATION OF NAPROXEN AS A POTENTIAL LINK TO ULCEROGENESIS IN H. PYLORI NEGATIVE INDIVIDUALS
The American Journal of Gastroenterology
2004 - ADMINISTRATION OF RABEPRAZOLE RESULTS IN RESTORATION OF NAPROXEN-INDUCED GASTRIC MUCIN PRODUCTION IMPAIRMENT
The American Journal of Gastroenterology
2004 - RESTORATIVE IMPACT OF RABEPRAZOLE ON GASTRIC MUCUS PRODUCTION IMPAIRMENT DURING NAPROSYN ADMINISTRATION: ITS POTENTIAL CLINICAL SIGNIFICANCE
The American Journal of Gastroenterology
2003
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”